Supplement Hype reports the state of evidence and grades claims. It is not a substitute for a doctor or pharmacist and does not diagnose, treat, or cure anything. Read the full disclaimer →
By goal
Ranked by the strength of human evidence — not popularity. 10 entries touch this goal. Each is graded claim by claim, because the same supplement can be strong for one use and weak for another.
the boring fiber that quietly works
One of the rare supplements where the evidence beats the hype. Cheap, unglamorous, and genuinely effective for cholesterol, regularity and blood sugar.
Marketing intensity 40 of 100. Evidence strength 80 of 100. Verdict: Better than its hype.
the underrated endurance and blood-pressure trick
Quietly effective and under-marketed. The nitrate in beetroot genuinely lowers blood pressure a little and improves endurance - a rare case of substance over hype.
Marketing intensity 45 of 100. Evidence strength 70 of 100. Verdict: Better than its hype.
strong for one thing, oversold for the rest
Strong for lowering high triglycerides. The blanket 'everyone needs fish oil for their heart' is a much weaker claim.
Marketing intensity 75 of 100. Evidence strength 60 of 100. Verdict: Slightly overhyped.
essential if low, oversold if not
Real and important if you're deficient. Marketed as a cure-all for people who already have enough.
Marketing intensity 80 of 100. Evidence strength 55 of 100. Verdict: Overhyped.
"nature's Ozempic"
Real metabolic effects, genuinely studied - but the viral 'nature's Ozempic' label is marketing fiction, and the drug interactions are the part TikTok skips.
Marketing intensity 88 of 100. Evidence strength 50 of 100. Verdict: Overhyped.
the pump amino acid — better than arginine, oversold for pumps
A legit nitric-oxide booster with some real recovery and endurance signal, but the evidence is mixed and single pre-workout doses often do nothing.
Marketing intensity 60 of 100. Evidence strength 45 of 100. Verdict: Slightly overhyped.
best case is for statin users and heart failure
A reasonable add-on for statin muscle aches and heart failure, where the evidence is mixed-to-promising. As a general 'energy and anti-aging' pill for healthy people, it's weak.
Marketing intensity 70 of 100. Evidence strength 45 of 100. Verdict: Overhyped.
the calcium-traffic-cop, on surrogate evidence
A plausible idea - help calcium land in bone, not arteries - with promising biomarker and imaging data. But hard clinical proof (fewer fractures, fewer heart attacks) isn't there yet.
Marketing intensity 70 of 100. Evidence strength 35 of 100. Verdict: Overhyped.
the 'fat burner' that can hurt your liver
A staple of fat-burner blends with barely-there weight-loss data - and a real, dose-dependent risk of liver injury, especially in the exact 'pill-plus-diet' scenario it's sold for.
Marketing intensity 75 of 100. Evidence strength 30 of 100. Verdict: Severely overhyped.
the red-wine longevity dream that didn't translate
The molecule that launched the longevity-supplement craze - on yeast and worms. In humans it's barely absorbed and the lifespan and heart claims haven't held up.
Marketing intensity 80 of 100. Evidence strength 25 of 100. Verdict: Severely overhyped.
Based on human evidence, the best-supported options here are Psyllium husk, Beetroot / dietary nitrate, Omega-3 (EPA/DHA fish oil). Each is graded claim by claim — open a card for the sources.
Watch out for Green tea extract (EGCG), Resveratrol — the marketing runs well ahead of the human evidence for these.